Mark H. Rachesky MD - 30 Jun 2021 Form 4 Insider Report for NAVISTAR INTERNATIONAL CORP

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jul 2021, 16:17:10 UTC
Prior SEC filing
21 Jun 2021
Next SEC filing
16 Sep 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Janet Yeung as attorney in fact

Key filing fact

Mark H. Rachesky MD filed Form 4 for NAVISTAR INTERNATIONAL CORP on 02 Jul 2021.

Key facts

  • This page summarizes Mark H. Rachesky MD's Form 4 filing for NAVISTAR INTERNATIONAL CORP.
  • 10 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 02 Jul 2021, 16:17.

Change

  • Previous filing in this sequence was filed on 21 Jun 2021.
  • Current net transaction value: -$374,950.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NAV transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-1,099,046
Change %
-100%
Price
Shares after
0
Date
01 Jul 2021
Ownership
See Footnotes
Footnotes
F1, F2, F7
NAV transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-145,426
Change %
-100%
Price
Shares after
0
Date
01 Jul 2021
Ownership
See Footnotes
Footnotes
F3, F4, F7
NAV transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-14,980,528
Change %
-100%
Price
Shares after
0
Date
01 Jul 2021
Ownership
See Footnotes
Footnotes
F5, F6, F7
NAV transaction

Common Stock

Award

Transaction value
$0
Shares
+758
Change %
+1.4%
Price
$0.000000
Shares after
53,396
Date
30 Jun 2021
Ownership
Direct
NAV transaction

Common Stock

Disposed to Issuer

Transaction value
Shares
-53,396
Change %
-100%
Price
Shares after
0
Date
01 Jul 2021
Ownership
Direct
Footnotes
F7

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NAV transaction Derivative

Stock Option (Right to Buy

Disposed to Issuer

Transaction value
$37,350
Shares
-5,000
Change %
-100%
Price
$7.47*
Shares after
0
Date
01 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$37.03
Footnotes
F8
NAV transaction Derivative

Stock Option (Right to Buy

Disposed to Issuer

Transaction value
$169,500
Shares
-5,000
Change %
-100%
Price
$33.90
Shares after
0
Date
01 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$10.60
Footnotes
F8
NAV transaction Derivative

Stock Option (Right to Buy

Disposed to Issuer

Transaction value
$67,800
Shares
-5,000
Change %
-100%
Price
$13.56
Shares after
0
Date
01 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$30.94
Footnotes
F8
NAV transaction Derivative

Stock Option (Right to Buy

Disposed to Issuer

Transaction value
$14,350
Shares
-5,000
Change %
-100%
Price
$2.87*
Shares after
0
Date
01 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$41.63
Footnotes
F8
NAV transaction Derivative

Stock Option (Right to Buy

Disposed to Issuer

Transaction value
$85,950
Shares
-5,000
Change %
-100%
Price
$17.19
Shares after
0
Date
01 Jul 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$27.31
Footnotes
F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Mark H. Rachesky MD is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 8 footnotes

Footnote F1

These shares are held for the account of MHR Capital Partners Master Account LP, an Anguilla, British West Indies limited partnership ("Master Account"). MHR Advisors LLC, a Delaware limited liability company ("Advisors"), is the general partner of Master Account. MHRC LLC, a Delaware limited liability company ("MHRC"), is the managing member of Advisors and in such capacity may be deemed to be the beneficial owner of the shares held for the account of Master Account. Mark H. Rachesky, M.D. ("Dr. Rachesky") is the managing member of MHRC. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Master Account. MHR Fund Management LLC ("Fund Management") has an investment management agreement with Master Account pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Master Account and, accordingly,

Footnote F2

(Continued from Footnote 1) Fund Management may be deemed to beneficially own the shares held for the account of Master Account. MHR Holdings LLC, a Delaware limited liability company ("MHR Holdings"), is the managing member of Fund Management and, in such capacity, may be deemed to beneficially own any shares that are deemed to be beneficially owned by Fund Management. Accordingly, MHR Holdings may be deemed to beneficially own the shares held for the account of Master Account.

Footnote F3

These shares are held for the account of MHR Capital Partners (100) LP, a Delaware limited partnership ("Capital Partners (100)"). Advisors is the general partner of Capital Partners (100). MHRC is the managing member of Advisors and in such capacity may be deemed to be the beneficial owner of the shares held for the account of Capital Partners (100). Dr. Rachesky is the managing member of MHRC. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Capital Partners (100). Fund Management has an investment management agreement with Capital Partners (100) pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Capital Partners (100) and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Capital Partners (100). (Continued to Footnote 4)

Footnote F4

(Continued from Footnote 3) MHR Holdings is the managing member of Fund Management and, in such capacity, may be deemed to beneficially own any shares that are deemed to be beneficially owned by Fund Management. Accordingly, MHR Holdings may be deemed to beneficially own the shares held for the account of Capital Partners (100).

Footnote F5

These shares are held for the account of MHR Institutional Partners III LP, a Delaware limited partnership ("Institutional Partners III"). MHR Institutional Advisors III LLC, a Delaware limited liability company "Institutional Advisors III") is the general partner of Institutional Partners III. Dr. Rachesky is the managing member of Institutional Advisors III. In such capacity, Dr. Rachesky may be deemed to be the beneficial owner of the shares held for the account of Institutional Partners III. Fund Management has an investment management agreement with Institutional Partners III pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the shares held for the account of Institutional Partners III and, accordingly, Fund Management may be deemed to beneficially own the shares held for the account of Institutional Partners III. (Continued to Footnote 6)

Footnote F6

(Continued from Footnote 5) MHR Holdings is the managing member of Fund Management and, in such capacity, may be deemed to beneficially own any shares that are deemed to be beneficially owned by Fund Management. Accordingly, MHR Holdings may be deemed to beneficially own the shares held for the account of Institutional Partners III.

Footnote F7

Pursuant to that certain Agreement and Plan of Merger, dated as of November 7, 2020 (the "Merger Agreement"), by and among Navistar International Corporation, a Delaware Corporation (the "Issuer"), TRATON SE, a Societas Europaea ("TRATON") and Dusk Inc., a Delaware Corporation and a wholly owned indirect subsidiary of TRATON ("Merger Sub"), Merger Sub was merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation and an indirect subsidiary of TRATON (the "Surviving Corporation"). As a result of the Merger, each share of Issuer Common Stock and each restricted share unit was automatically converted into the right to receive an amount in cash equal to $44.50 (the "Merger Consideration").

Footnote F8

Pursuant to the Merger Agreement, each option to purchase shares of Issuer Common Stock of the Issuer, whether vested or unvested, was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (a) the amount by which $44.50 exceeds the per-share exercise price of such option, by (b) the total number of shares of Issuer Common Stock underlying such option. The original terms of the option provided for vesting in three annual installments with one-third of the option vesting on each anniversary date of the grant, so that in three years the option was fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .